MarkMeterskyMD

Critical Care Medicine, Infectious Disease, Pleural Disease

Professor, University of Connecticut School of Medicine

Dr. Metersky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
263 Farmington Ave
Farmington, CT 06030
Phone+1 860-679-3343

Fax+1 860-679-4256

University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
New York University School of MedicineClass of 1985

Scleroderma Lung Disease Start of enrollment: 1999 Aug 01
Completed
Phase 3
Bosentan for Poorly Controlled Asthma Start of enrollment: 2008 Dec 01
Terminated
Phase 2

PubMed

Respiratory syncytial virus pulmonary infections in adults - disease burden and prevention.
Grant W Waterer, Mark Metersky
Current Opinion in Pulmonary Medicine. 2024-12-24
1 citations
Hospital COVID-19 Burden and Adverse Event Rates.
Mark L Metersky, David Rodrick, Shih-Yieh Ho, Deron Galusha, Andrea Timashenka
JAMA Network Open. 2024-11-04
Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM researc...
Ashwin Basavaraj, Amanda E Brunton, Radmila Choate, Alan Barker, Kunal Jakharia
Respiratory Medicine and Research. 2024-11-01

Journal Articles

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Mark L Metersky, Charles L Daley, The New England Journal of Medicine
Association Between Medicare Expenditures and Adverse Events for Patients with Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United States
Mark L Metersky, Harlan M Krumholz, JAMA Network Open
Case Report Bordetella Bronchiseptica in Non-Cystic Fibrosis Bronchiectasis
Vanessa L Yap, Elham Karamooz, Mark L Metersky, Alan F Barker, ScienceDirect

Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016
Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016

COVID-19 Burden in Hospitals Affects Risk for in-Hospital Adverse EventsNovember 8th, 2024
U.S. Hospitals Are Getting Safer for Patients, Study FindsJuly 20th, 2022
COPD as a Lung Stem Cell Disease: Single Cell Cloning Tells the Story of Abnormal CellsApril 15th, 2020
Join now to see all

Obstacles To Usage Of The Pneumoccocal VaccineNational Center For Research Resources1998–1999
Compliance With Tuberculosis Prophylaxis After Release For Correctional FacilityNational Center For Research Resources1998–1999